My Gene Counsel
  • Biotechnology
  • Clinical Care Systems
  • Precision Medicine Partners
  • Solutions
    • Family History & Assessment
    • Living Lab Reports
    • Long-Term Notifications
  • Media
    • Genetic Journal
    • News
    • Press Releases
    • Multimedia
    • Publications
    • Career Resources
    • Case Series
  • About Us
  • Login
Select Page
A Genetic Counselor’s Take on Why America Should Not Collect DNA From Migrants

A Genetic Counselor’s Take on Why America Should Not Collect DNA From Migrants

by Danielle Bonadies | Jan 31, 2020 | News

Last week, three House Democrats called on the Department of Homeland Security (DHS) to stop collecting DNA from migrants in government custody. Democratic Reps. Rashida Tlaib (MI), Veronica Escobar (TX), and Congressional Hispanic Caucus...
Mirror, Mirror, On the Wall: The Epigenetics of Aging

Mirror, Mirror, On the Wall: The Epigenetics of Aging

by Danielle Bonadies | Jan 24, 2020 | News

A few months ago, I received an email from a company called Chronomics that tests for epigenetic changes in your DNA. I’m still a bit scarred from my personal direct-to-consumer testing experience, so I was initially reluctant to explore yet another genetic...
With More Than a Million Records, ClinVar Value Grows as Variant Classification Resource

With More Than a Million Records, ClinVar Value Grows as Variant Classification Resource

by Danielle Bonadies | Jan 9, 2020 | News

Since its launch in 2013, ClinVar has not only amassed a wealth of genetic variant information, but the lab and clinical genetics community in the US are readily referencing it when they have questions about the clinical significance of variants. A few healthcare...
Precision Oncology in 2019: Growing Options Highlight Gaps in Healthcare Delivery System

Precision Oncology in 2019: Growing Options Highlight Gaps in Healthcare Delivery System

by Danielle Bonadies | Jan 2, 2020 | News

2019 was another banner year for precision oncology with the approval of a number of drugs targeting novel genomic alterations, the availability of a third pan-cancer indication, and the commercial launch of new biomarker tests for predicting drug response, such as...
Personalized Medicine in 2019: Options Increasing But Are They Reaching Patients?

Personalized Medicine in 2019: Options Increasing But Are They Reaching Patients?

by Danielle Bonadies | Jan 2, 2020 | News

In 2019, the field of personalized medicine continued to grow with the market launch of more than two dozen drugs targeting novel genomic alterations and numerous genetic tests to determine whether patients are at risk for serious diseases like cancer, and whether...
< First< Prev...7891011...Next >Last >

Recent Posts

  • Genetic Counselors in the C-Suite
  • Oncology Insights: The Speed and Scope of Genetic Updates Expanding Genetic Testing to Advance Precision Medicine
  • My Gene Counsel and FamGenix Announce Strategic Partnership to Transform Genetic Risk Assessment and Patient Education
  • Genetic Counseling Toolkit For Students
  • 2024 STEM Gift Guide

Archives

  • About Us
  • One-Stop Solution
  • Living Lab Reports®
  • Media
  • Genetic Journal Blog
  • Career Resources
  • Population Studies
  • Healthcare Systems
  • Precision Medicine Partners
  • Contact Us
  • FAQs
  • Privacy Policy

The My Gene Counsel portal and website should not be construed, directly or indirectly, as the practice of medicine or dispensing of medical services by My Gene Counsel or its Partners.

My Gene Counsel   ©